OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Biomarker ConsortiumInteractive ToolsLearning ModulesPresentationsSponsored
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
Business Management
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
Advertisement

October 1, 2014

home / news-network / october-1
Advertisement
Latest News & Insight: October 1, 2014

EP. 1: Latest News & Insight: October 1, 2014

October 1st 2014
BRCA Screening Recommendations by Geneticist Mary-Claire King

EP. 2: BRCA Screening Recommendations by Geneticist Mary-Claire King

October 1st 2014
ATEMPT Trial at Dana-Farber Cancer Institute

EP. 3: ATEMPT Trial at Dana-Farber Cancer Institute

October 1st 2014
Prophylactic Double Mastectomy-Does it Make a Difference?

EP. 4: Prophylactic Double Mastectomy-Does it Make a Difference?

October 1st 2014
The Ongoing Debate Over Mammography-Screening Matters

EP. 5: The Ongoing Debate Over Mammography-Screening Matters

October 1st 2014
Dr. Patrick Borgen on the Future of Breast Cancer Treatment

EP. 6: Dr. Patrick Borgen on the Future of Breast Cancer Treatment

October 1st 2014
Advertisement
Dr. Patrick Borgen Discusses the "Jolie Effect"

EP. 7: Dr. Patrick Borgen Discusses the "Jolie Effect"

October 1st 2014
Dr. Patrick Borgen Talks About Advances in Breast Cancer

EP. 8: Dr. Patrick Borgen Talks About Advances in Breast Cancer

October 1st 2014
Is Breast Cancer Vaccination Coming?

EP. 9: Is Breast Cancer Vaccination Coming?

October 1st 2014

Latest Conference Coverage

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

First-line Toripalimab Plus Sorafenib Elicits Responses in Unresectable Hepatocellular Carcinoma

Data for Luspatercept Highlight Evolving Treatment Landscape in Lower-Risk MDS

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact